“Efficacy of Dapagliflozin versus Empagliflozin on Glycemic Control and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus”, World Journal of Current Med and Pharm Research, vol. 8, no. 2, pp. 185–189, Aug. 2026, doi: 10.37022/wjcmpr.v8i2.415.